The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Memantine Grindeks 10 mg film-coated tablets

AS GrindeksPA22992/003/001

Main Information

Trade NameMemantine Grindeks 10 mg film-coated tablets
Active SubstancesMemantine Hydrochloride
Dosage FormFilm-coated tablet
Licence HolderAS Grindeks
Licence NumberPA22992/003/001

Group Information

ATC CodeN06DX01 memantine


License statusAuthorised
Licence Issued05/03/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0022-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back